2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol

We are 2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol CAS:83282-91-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol
CAS.NO:83282-91-1
Synonyms:2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol
4-Methoxymethyl-2,3,5,6-tetrafluorobenzyl alcohol
Molecular Formula:C9H8F4O2
Molecular Weight:224.15
 
Physical and Chemical Properties:
Density:1.407
Boiling point:214ºC
Flash point:107ºC
Index of Refraction:1.464
 
Specification:
Appearance:Off-white crystal
Assay:≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:transfluthrin and Tefluthrin intermediate

2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol


Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).3-BROMO-5-FLUOROBENZALDEHYDE The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.Trichloro(3,3,3-trifluoropropyl)silane CAS:592-09-6 China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price.5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)-1,3-benzoxazole CAS:1276666-13-7 The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.

Related Products
Product Name
2-Fluoro-4-nitrotoluene View Details
2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethanamine View Details
1-(3-bromophenyl)-2-phenyl-1H-benzo[d]imidazole View Details
4-(Trifluoromethyl)benzonitrile manufacturer N-(3-trimethoxysilylpropyl)butan-1-amine manufacturer Triphenylmethyl Chloride manufacturer 3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)prop-2-enoic acid manufacturer 3,4-Difluorobenzyl Bromide manufacturer